Other Events ·
GH Research presents clinical trial data at ECNP meeting in Munich
GHRSGH Research PLC
GH Research PLC announced the presentation of data from its GH001-TRD-201 and GH001-BD-202 clinical trials at the 39th European College of Neuropsychopharmacology (ECNP) annual meeting. The presentations will occur during Poster Session 2 on October 11, 2026, in Munich, Germany, delivered by Prof. Wiesław J. Cubała, Prof. Bernhard T. Baune, and Dr. Max de Leeuw. Additionally, the company is sponsoring a satellite symposium titled “Achieving remission in treatment-resistant depression: current evidence and research on rapid-acting antidepressants” on October 10, 2026. GH Research PLC operates as a clinical-stage biopharmaceutical company focused on developing novel treatments for psychiatric disorders.